Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical and therapeutic applications relating to a type 9 adenylyl cyclase Polymorphism in asthma and reversible bronchial obstruction

Pharmaceutical and therapeutic applications relating to a type 9 adenylyl cyclase Polymorphism in asthma and reversible bronchial obstruction

US Patent 8071287 · Granted Dec 6, 2011

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bronchodilators for treating obstructive lung disease2025
Biased adrenergic agonists2024
Inhibition of beta-arrestin oligomerization in tauopathy2024
Compositions and methods to reduce beta-agonist-mediated tachyphylaxis2021
Methods of treating obstructive lung diseases using bitter tastants2017
Methods for treatment with bucindolol based on genetic targeting2014
G-protein coupled receptor kinase-5 polymorphism2013
Methods for treatment with bucindolol based on genetic targeting2012
Methods for treatment with bucindolol based on genetic targeting2011
Methods for treatment with bucindolol based on genetic targeting2010
Heart failure assessment based on alpha-2C adrenergic receptor polymorphisms2010
Alpha-2 adrenergic receptor polymorphisms2009